ARDT PE Ratio & Valuation, Is ARDT Overvalued

Historical Valuation

Ardent Health Inc (ARDT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 6.72 is considered Undervalued compared with the five-year average of 8.19. The fair price of Ardent Health Inc (ARDT) is between 11.40 to 15.03 according to relative valuation method. Compared to the current price of 8.56 USD , Ardent Health Inc By Undervalued By 24.92%.

Relative Value

Fair Zone

11.40-15.03

Current Price：8.56

24.92%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Ardent Health Inc (ARDT) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Ardent Health Inc (ARDT) has a current Price-to-Book (P/B) ratio of 0.72. Compared to its 3-year average P/B ratio of 3.32, the current P/B ratio is approximately -78.18% higher. Relative to its 5-year average P/B ratio of 3.32, the current P/B ratio is about -78.18% higher. Ardent Health Inc (ARDT) has a Forward Free Cash Flow (FCF) yield of approximately 20.85%. Compared to its 3-year average FCF yield of 8.19%, the current FCF yield is approximately 154.63% lower. Relative to its 5-year average FCF yield of 8.19%, the current FCF yield is about 154.63% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ARDT competitors is 0.17, providing a benchmark for relative valuation. Ardent Health Inc Corp (ARDT.N) exhibits a P/S ratio of 0.17, which is 0% above the industry average. Given its robust revenue growth of -0.08%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ARDT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ARDT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ARDT currently overvalued or undervalued?

What is Ardent Health Inc (ARDT) fair value?

ARDT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Ardent Health Inc (ARDT) is between 11.40 to 15.03 according to relative valuation method.

How does ARDT's valuation metrics compare to the industry average?

The average P/S ratio for ARDT's competitors is 0.17, providing a benchmark for relative valuation. Ardent Health Inc Corp (ARDT) exhibits a P/S ratio of 0.17, which is 0.00% above the industry average. Given its robust revenue growth of -0.08%, this premium appears unsustainable.

What is the current P/B ratio for Ardent Health Inc (ARDT) as of Apr 02 2026?

As of Apr 02 2026, Ardent Health Inc (ARDT) has a P/B ratio of 0.72. This indicates that the market values ARDT at 0.72 times its book value.

What is the current FCF Yield for Ardent Health Inc (ARDT) as of Apr 02 2026?

As of Apr 02 2026, Ardent Health Inc (ARDT) has a FCF Yield of 20.85%. This means that for every dollar of Ardent Health Inc's market capitalization, the company generates 20.85 cents in free cash flow.

What is the current Forward P/E ratio for Ardent Health Inc (ARDT) as of Apr 02 2026?

As of Apr 02 2026, Ardent Health Inc (ARDT) has a Forward P/E ratio of 6.72. This means the market is willing to pay $6.72 for every dollar of Ardent Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Ardent Health Inc (ARDT) as of Apr 02 2026?

As of Apr 02 2026, Ardent Health Inc (ARDT) has a Forward P/S ratio of 0.18. This means the market is valuing ARDT at $0.18 for every dollar of expected revenue over the next 12 months.

ARDT Valuation